共 376 条
[1]
El-Serag K(2014)Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 60 1767-1775
[2]
Mittal S(2013)Epidemiology of hepatocellular carcinoma: consider the population J Clin Gastroenterol 47 Suppl S2-S6
[3]
Mittal S(2007)Epidemiology of hepatocellular carcinoma in Hispanics in the United States Arch Intern Med. 167 1983-1989
[4]
El-Serag HB(2007)Strategies for the management of hepatocellular carcinoma Nat Clin Pract Oncol 4 424-432
[5]
El-Serag HB(2010)Hepatocellular carcinoma: a global view Nat Rev Gastroenterol Hepatol 7 448-458
[6]
El-Serag HB(2003)Future perspectives for hepatocellular carcinoma HBP 5 206-213
[7]
Lau M(2004)The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma Liver Transpl 10 S115-S120
[8]
Eschbach K(2001)Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma Arch Surg 136 528-535
[9]
Davila J(2008)The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE) J Med Assoc Thai 91 1539-1543
[10]
Goodwin J(2008)Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors J Vasc Interv Radiol 19 1483-1489